Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Anders

Showing results (221-230 of 247) with videos related to

Pageof 25
Sort By:
JCO Clinical Cancer Informatics|October 18, 2021
Pediatric Cancer Data Commons: Federating and Democratizing Data for Childhood Cancer ResearchAlejandro Plana, Brian Furner, Monica Palese, et al.
Blood Advances|November 4, 2022
Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: an I-BFM Study Group collaborationAnne Sofie Borg Hammer, Kristian Løvvik Juul-Dam, Julie Damgaard Sandahl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2025
Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children's Oncology GroupBenjamin J Huang, Lauren K Meyer, Todd A Alonzo, et al.
Blood Advances|May 3, 2021
Mesothelin is a novel cell surface disease marker and potential therapeutic target in acute myeloid leukemiaAllison J Kaeding, Sonali P Barwe, Anilkumar Gopalakrishnapillai, et al.
Scientific Reports|March 23, 2025
Quantifying the impact of workshops promoting microbiome data standards and data stewardshipJulia M Kelliher, Francisca E Rodriguez, Leah Y D Johnson, et al.
Blood Advances|October 22, 2025
Molecular Risk Markers Define Risk of Relapse in Myeloid Leukemia of Down syndrome Beyond Measurable Residual DiseaseJason N Berman, Anupam Verma, Shelton A Viola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2021
The B7-H3-Targeting Antibody-Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor ModelsNathan M Kendsersky, Jarrett Lindsay, E Anders Kolb, et al.
Applied and Environmental Microbiology|January 8, 2025
Metagenomics reveals spatial variation in cyanobacterial composition, function, and biosynthetic potential in the Winam Gulf, Lake Victoria, KenyaLauren N Hart, Brittany N Zepernick, Kaela E Natwora, et al.
Pediatric Blood & Cancer|October 27, 2006
The pediatric preclinical testing program: description of models and early testing resultsPeter J Houghton, Christopher L Morton, Chandra Tucker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2019
Comprehensive Transcriptome Profiling of Cryptic <i>CBFA2T3-GLIS2</i> Fusion-Positive AML Defines Novel Therapeutic Options: A COG and TARGET Pediatric AML StudyJenny L Smith, Rhonda E Ries, Tiffany Hylkema, et al.
Pageof 25

Showing results (221-230 of 247) with videos related to

Sort By:
Pageof 25
JCO Clinical Cancer Informatics|October 18, 2021
Pediatric Cancer Data Commons: Federating and Democratizing Data for Childhood Cancer ResearchAlejandro Plana, Brian Furner, Monica Palese, et al.
Blood Advances|November 4, 2022
Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: an I-BFM Study Group collaborationAnne Sofie Borg Hammer, Kristian Løvvik Juul-Dam, Julie Damgaard Sandahl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2025
Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children's Oncology GroupBenjamin J Huang, Lauren K Meyer, Todd A Alonzo, et al.
Blood Advances|May 3, 2021
Mesothelin is a novel cell surface disease marker and potential therapeutic target in acute myeloid leukemiaAllison J Kaeding, Sonali P Barwe, Anilkumar Gopalakrishnapillai, et al.
Scientific Reports|March 23, 2025
Quantifying the impact of workshops promoting microbiome data standards and data stewardshipJulia M Kelliher, Francisca E Rodriguez, Leah Y D Johnson, et al.
Blood Advances|October 22, 2025
Molecular Risk Markers Define Risk of Relapse in Myeloid Leukemia of Down syndrome Beyond Measurable Residual DiseaseJason N Berman, Anupam Verma, Shelton A Viola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2021
The B7-H3-Targeting Antibody-Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor ModelsNathan M Kendsersky, Jarrett Lindsay, E Anders Kolb, et al.
Applied and Environmental Microbiology|January 8, 2025
Metagenomics reveals spatial variation in cyanobacterial composition, function, and biosynthetic potential in the Winam Gulf, Lake Victoria, KenyaLauren N Hart, Brittany N Zepernick, Kaela E Natwora, et al.
Pediatric Blood & Cancer|October 27, 2006
The pediatric preclinical testing program: description of models and early testing resultsPeter J Houghton, Christopher L Morton, Chandra Tucker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2019
Comprehensive Transcriptome Profiling of Cryptic <i>CBFA2T3-GLIS2</i> Fusion-Positive AML Defines Novel Therapeutic Options: A COG and TARGET Pediatric AML StudyJenny L Smith, Rhonda E Ries, Tiffany Hylkema, et al.
Pageof 25